Disseminated tuberculosis in a Crohn's disease patient on anti-TNFα therapy despite chemoprophylaxis

Gut

Volumn 57, Issue 3, 2008, Pages 425-

  Bourikas, L A ^a   Kourbeti, I S ^a   Koutsopoulos, A V ^a   Koutroubakis, I E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LYMPH NODE BIOPSY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; MALE; OPPORTUNISTIC INFECTIONS; TUBERCULOSIS; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM; TUBERCULOSIS, GASTROINTESTINAL; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39649096746     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.132407     Document Type: Letter

References (3)

1. Gomez-Reino JJ, Carmona L, Angel Descalzo M: Biobadaser Group. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007;57:756-61.
2. Sichletidis L, Settas L, Spyratos D, et al. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 2006;10:1127-32.
3. Tahaoglu K, Torun T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001;345:170-4.